NCT00004919View on ClinicalTrials.gov

Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

March 31, 2003

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG

cisplatin

Given IV

DRUG

irinotecan hydrochloride

Given IV

DRUG

amifostine trihydrate

Given IV

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

91006-3776

COG Phase I Consortium, Arcadia

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00004919 - Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | Biotech Hunter | Biotech Hunter